{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:34:52Z","timestamp":1773282892921,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Finnish Dermatological Society","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incidence of keratinocyte carcinomas is increasing worldwide and currently there is no standardised strategy for the follow-up of patients with multiple tumours. The objective of this study was to assess the prevalence of premalignant lesions, i.e., actinic keratosis and Bowen\u2019s disease, as well as basal cell carcinoma (BCC) and cutaneous melanoma (CM) among patients with cutaneous squamous cell carcinoma (cSCC). Pathology database search was performed to identify all cSCC patients diagnosed in the Pirkanmaa region of Finland in 2006\u20132015. Details of the patients and tumours were obtained through medical record review. The cohort consisted of 774 patients with 1131 cSCC tumours. Overall 559 patients (72%) had premalignant lesions. A total of 316 patients (41%) had BCC and 52% of these (<jats:italic>n<\/jats:italic>\u2009=\u2009164) had more than one BCC tumour. 50 patients (6%) had CM. Overall 180 cSCC patients (23%) had no premalignant changes, BCC or CM. The median age of these patients was 6\u00a0years less than that of the patients with premalignant lesions (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) or BCC (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The invasion depth of the tumours was deeper in the patients with only cSCC (median 3\u00a0mm, interquartile range 2\u20136) than in those with premalignant lesions or BCC (median 2\u00a0mm, interquartile range 1\u20133), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001. CSCC patients have a high risk of developing multiple skin cancers and need long-term follow-up.<\/jats:p>","DOI":"10.1007\/s00403-020-02114-w","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T11:02:32Z","timestamp":1596970952000},"page":"879-884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma"],"prefix":"10.1007","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2990-679X","authenticated-orcid":false,"given":"Niina","family":"Korhonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leea","family":"Ylitalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiina","family":"Luukkaala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Itkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henni","family":"H\u00e4ih\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Jernman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erna","family":"Snellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Palve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,9]]},"reference":[{"issue":"5","key":"2114_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","volume":"166","author":"A Lomas","year":"2012","unstructured":"Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166(5):1069\u20131080","journal-title":"Br J Dermatol"},{"key":"2114_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jnci\/djw268","volume":"109","author":"S Wu","year":"2017","unstructured":"Wu S, Cho E, Li WQ, Qureshi AA (2017) History of keratinocyte carcinoma and risk of melanoma: a prospective cohort study. J Natl Cancer Inst 109:4. https:\/\/doi.org\/10.1093\/jnci\/djw268","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2114_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/jdv.14587","volume":"32","author":"RJT van der Leest","year":"2018","unstructured":"van der Leest RJT, Hollestein LM, Liu L, Nijsten T, de Vries E (2018) Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in dutch population-based cohorts: 1989\u20132009. J Eur Acad Dermatol Venereol 32(3):382\u2013389","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"14","key":"2114_CR4","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","volume":"51","author":"A Stratigos","year":"2015","unstructured":"Stratigos A, Garbe C, Lebbe C et al (2015) Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 51(14):1989\u20132007","journal-title":"Eur J Cancer"},{"issue":"1","key":"2114_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/bjd.15107","volume":"176","author":"D de Berker","year":"2017","unstructured":"de Berker D, McGregor JM, Mohd Mustapa MF, Exton LS, Hughes BR (2017) British association of dermatologists\u2019 guidelines for the care of patients with actinic keratosis 2017. Br J Dermatol 176(1):20\u201343","journal-title":"Br J Dermatol"},{"issue":"1","key":"2114_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2340\/00015555-2175","volume":"96","author":"M Overmark","year":"2016","unstructured":"Overmark M, Koskenmies S, Pitkanen S (2016) A retrospective study of treatment of squamous cell carcinoma in situ. Acta Derm Venereol 96(1):64\u201367","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"2114_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1046\/j.1365-4362.1998.00467.x","volume":"37","author":"MA Mittelbronn","year":"1998","unstructured":"Mittelbronn MA, Mullins DL, Ramos-Caro FA, Flowers FP (1998) Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol 37(9):677\u2013681","journal-title":"Int J Dermatol"},{"issue":"7","key":"2114_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1047-2797(01)00276-9","volume":"12","author":"JT Efird","year":"2002","unstructured":"Efird JT, Friedman GD, Habel L, Tekawa IS, Nelson LM (2002) Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol 12(7):469\u2013475","journal-title":"Ann Epidemiol"},{"issue":"6","key":"2114_CR9","doi-asserted-by":"publisher","first-page":"e99674","DOI":"10.1371\/journal.pone.0099674","volume":"9","author":"JR Rees","year":"2014","unstructured":"Rees JR, Zens MS, Gui J, Celaya MO, Riddle BL, Karagas MR (2014) Non melanoma skin cancer and subsequent cancer risk. PLoS ONE 9(6):e99674","journal-title":"PLoS ONE"},{"issue":"4","key":"2114_CR10","doi-asserted-by":"publisher","first-page":"e1001433","DOI":"10.1371\/journal.pmed.1001433","volume":"10","author":"F Song","year":"2013","unstructured":"Song F, Qureshi AA, Giovannucci EL et al (2013) Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med 10(4):e1001433","journal-title":"PLoS Med"},{"key":"2114_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1471-2407-14-210","volume":"14","author":"TE Robsahm","year":"2014","unstructured":"Robsahm TE, Karagas MR, Rees JR, Syse A (2014) New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway. BMC Cancer 14:210","journal-title":"BMC Cancer"},{"key":"2114_CR12","unstructured":"Official Statistics of Finland (OSF). Population structure [e-publication]. ISSN=1797\u20135395. Helsinki: Statistics Finland [referred: 11.8.2018]. Access Method: http:\/\/www.stat.fi\/til\/vaerak\/index_en.html."},{"issue":"4","key":"2114_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2340\/00015555-3110","volume":"99","author":"N Korhonen","year":"2019","unstructured":"Korhonen N, Ylitalo L, Luukkaala T et al (2019) Characteristics and trends of cutaneous squamous cell carcinoma in a patient cohort in Finland 2006\u20132015. Acta Derm Venereol 99(4):412\u2013416","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"2114_CR14","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.ejca.2013.03.010","volume":"49","author":"SC Flohil","year":"2013","unstructured":"Flohil SC, van der Leest RJ, Arends LR, de Vries E, Nijsten T (2013) Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer 49(10):2365\u20132375","journal-title":"Eur J Cancer"},{"issue":"6","key":"2114_CR15","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jid.2016.02.008","volume":"136","author":"DC Whiteman","year":"2016","unstructured":"Whiteman DC, Thompson BS, Thrift AP et al (2016) A model to predict the risk of keratinocyte carcinomas. J Invest Dermatol 136(6):1247\u20131254","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2114_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jaad.2014.04.019","volume":"71","author":"MM Asgari","year":"2014","unstructured":"Asgari MM, Warton EM, Quesenberry CP, Koralek DO, Taylor M (2014) Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma. J Am Acad Dermatol 71(3):521\u2013528","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2114_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jamadermatol.2014.3307","volume":"151","author":"MR Wehner","year":"2015","unstructured":"Wehner MR, Linos E, Parvataneni R, Stuart SE, Boscardin WJ, Chren MM (2015) Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. JAMA Dermatol 151(4):382\u2013388","journal-title":"JAMA Dermatol"},{"issue":"8","key":"2114_CR18","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/jid.2013.134","volume":"133","author":"SC Flohil","year":"2013","unstructured":"Flohil SC, van der Leest RJ, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T (2013) Prevalence of actinic keratosis and its risk factors in the general population: the rotterdam study. J Invest Dermatol 133(8):1971\u20131978","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2114_CR19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/bjd.13132","volume":"171","author":"J Eder","year":"2014","unstructured":"Eder J, Prillinger K, Korn A, Geroldinger A, Trautinger F (2014) Prevalence of actinic keratosis among dermatology outpatients in austria. Br J Dermatol 171(6):1415\u20131421","journal-title":"Br J Dermatol"},{"issue":"3","key":"2114_CR20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bjd.12420","volume":"169","author":"RN Werner","year":"2013","unstructured":"Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A (2013) The natural history of actinic keratosis: a systematic review. Br J Dermatol 169(3):502\u2013518","journal-title":"Br J Dermatol"},{"issue":"5","key":"2114_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/jdv.12848","volume":"29","author":"MT Fernandez-Figueras","year":"2015","unstructured":"Fernandez-Figueras MT, Carrato C, Saenz X et al (2015) Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin. J Eur Acad Dermatol Venereol 29(5):991\u2013997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2114_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04296.x","volume":"5","author":"JJ Bonerandi","year":"2011","unstructured":"Bonerandi JJ, Beauvillain C, Caquant L et al (2011) Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol 25:1\u201351 (Suppl 5)","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"2114_CR23","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1097\/DSS.0000000000000478","volume":"41","author":"AN Kauvar","year":"2015","unstructured":"Kauvar AN, Arpey CJ, Hruza G, Olbricht SM, Bennett R (2015) Consensus for nonmelanoma skin cancer treatment, part II: squamous cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg 41(11):1214\u20131240","journal-title":"Dermatol Surg"},{"issue":"2","key":"2114_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/jamadermatol.2016.4070","volume":"153","author":"P Subramaniam","year":"2017","unstructured":"Subramaniam P, Olsen CM, Thompson BS, Whiteman DC, Neale RE, QSkin Sun, and Health Study Investigators (2017) Anatomical distributions of basal cell carcinoma and squamous cell carcinoma in a population-based study in Queensland. Australia JAMA Dermatol 153(2):175\u2013182","journal-title":"Australia JAMA Dermatol"},{"issue":"10","key":"2114_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1445-2197.2009.05094.x","volume":"79","author":"PJ Terrill","year":"2009","unstructured":"Terrill PJ, Fairbanks S, Bailey M (2009) Is there just one lesion? The need for whole body skin examination in patients presenting with non-melanocytic skin cancer. ANZ J Surg 79(10):707\u2013712","journal-title":"ANZ J Surg"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02114-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02114-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02114-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T09:25:24Z","timestamp":1635240324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02114-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,9]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2114"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02114-w","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,9]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicting interests"}}]}}